Palmitoleic acid (POA) is an n-7 monounsaturated fatty acid.
Pre-clinical studies suggest cis-POA lowers inflammation and improves metabolism.
However, the impact of POA supplementation on inflammatory/metabolic biomarkers in humans is not well understood.
